Emmessar Biotech & Nutrition Limited (BOM:524768)
25.99
-0.21 (-0.80%)
At close: May 26, 2026
BOM:524768 Revenue
In the fiscal year ending March 31, 2026, Emmessar Biotech & Nutrition had annual revenue of 24.07M INR with 12.75% growth. Emmessar Biotech & Nutrition had revenue of 5.66M in the quarter ending March 31, 2026, with 159.49% growth.
Revenue
24.07M
Revenue Growth
+12.75%
P/S Ratio
5.38
Revenue / Employee
1.50M
Employees
16
Market Cap
129.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 24.07M | 2.72M | 12.75% |
| Mar 31, 2025 | 21.35M | 929.00K | 4.55% |
| Mar 31, 2024 | 20.42M | -4.73M | -18.82% |
| Mar 31, 2023 | 25.15M | 7.42M | 41.83% |
| Mar 31, 2022 | 17.73M | -66.83M | -79.03% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.55B |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 176.65M |
| Unjha Formulations | 157.49M |
| Zenith Healthcare | 113.86M |
| Norris Medicines | 94.44M |
| Colinz Laboratories | 61.36M |
| Desh Rakshak Aushdhalaya | 57.72M |